Ukraine, Russia: Peace Summit Highlights Western War Fatigue, Ukraine's Limited Support in Global South

Jun 17, 2024 | 15:26 GMT

Switzerland: Europe's Top Human Rights Court Rules Against Bern in Landmark Climate Change Case

Apr 9, 2024 | 15:25 GMT

India: Government Signs Trade Agreement Worth $100B With EFTA

Mar 11, 2024 | 19:36 GMT

Switzerland: Right-Wing Party Wins Swiss Federal Election

Oct 23, 2023 | 18:28 GMT

U.K., Switzerland: Governments Kick off Trade Negotiations

May 15, 2023 | 15:55 GMT

Switzerland: Zurich Insurance Exits Net-Zero Insurance Alliance

Apr 6, 2023 | 15:20 GMT

Switzerland, Ukraine: Swiss Parliament to Approve Reexport of Arms to Kyiv

Jan 25, 2023 | 19:56 GMT

Switzerland, Ukraine: Ransomware Operators Arrested in Police Bust

Oct 29, 2021 | 19:19 GMT
The European Free Trade Association: Norway, Switzerland, Liechtenstein and Norway
AssessmentsNov 6, 2017
Trade Profile: The Fate of Europe's Other Trade Bloc Hangs in the Balance
SnapshotsMar 31, 2017
U.S.: President Signs 2 Orders on Trade
Stratfor's graphic of the day features a standout geopolitical map, chart, image or data visualization reflecting global and regional trends and events.
GraphicsMar 30, 2017
Which Currency Could Replace the Dollar?
After Federal Reserve Board Chair Janet Yellen announced a hike in the U.S. benchmark lending rate March 15, the People's Bank of China bumped its rate up as well. But other major central banks declined to follow suit.
ReflectionsMar 16, 2017
Where the Fed Goes, Other Central Banks May Not Follow
The Beau-Rivage Palace hotel in Lausanne, Switzerland. The politically neutral space hotels provide can make them ideal spaces for leaders to convene for consultation in times of crisis.
On the RoadMar 5, 2017
The Temporary Halls of Power
The CRISPR-Cas9 gene editing complex from Streptococcus pyogenes. Technologies such as CRISPR have wide-ranging implications for agriculture, industrial biotechnology and human health care. The fight for ownership of the powerful gene-editing technique known as CRISPR-Cas9 is over, at least for now. The victor in the patent case, however, is less important than the fact that policy continues to lag behind scientific progress.
AssessmentsFeb 16, 2017
A Resolution on Who Owns Gene Editing
Load More